1 |
ESR1
| [9] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D00105
D00105
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
2 |
ESR1
| [9] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D01413
D01413
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
3 |
ESR1
| [9] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D01617
D01617
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
4 |
ESR1
| [9] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D01953
D01953
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
5 |
ESR1
| [9] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D04061
D04061
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
6 |
ESR1
| [9] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D04063
D04063
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
7 |
ESR1
| [9] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D04064
D04064
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
8 |
ESR1
| [9] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D04065
D04065
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
9 |
ESR2
| [7] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D00105
D00105
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
10 |
ESR2
| [7] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D01413
D01413
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
11 |
ESR2
| [7] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D01617
D01617
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
12 |
ESR2
| [7] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D01953
D01953
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
13 |
ESR2
| [7] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D04061
D04061
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
14 |
ESR2
| [7] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D04063
D04063
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
15 |
ESR2
| [7] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D04064
D04064
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
16 |
ESR2
| [7] Endocrine resistance Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer | D04065
D04065
|
Estradiol
| [7] 13 13, 46, 49, 65, 76, 226, 299 |
17 |
GHR
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Growth hormone synthesis, secretion and action | D02691
D02691
|
Somatotropin
| [23] 2 2, 3, 13, 19, 46, 65, 74, 75, 76, 78, 96, 107, 113, 187, 191, 193, 195, 236, 238, 265, 274, 276, 299 |
18 |
GNRHR
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, GnRH signaling pathway | D00988
D00988
|
Gonadorelin
| [1] 76 76 |
19 |
GNRHR
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, GnRH signaling pathway | D00989
D00989
|
Leuprolide
| [5] 1 1, 2, 3, 51, 76 |
20 |
GNRHR
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, GnRH signaling pathway | D02369
D02369
|
Histrelin
| [1] 76 76 |
21 |
GNRHR
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, GnRH signaling pathway | D03267
D03267
|
Gonadorelin
| [1] 76 76 |
22 |
GNRHR
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, GnRH signaling pathway | D04361
D04361
|
Gonadorelin
| [1] 76 76 |
23 |
GNRHR
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, GnRH signaling pathway | D06247
D06247
|
Triptorelin
| [2] 49 49, 76 |
24 |
GNRHR
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, GnRH signaling pathway | D08027
D08027
|
Gonadorelin
| [1] 76 76 |
25 |
AR
| [4] Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer | D00075
D00075
|
Testosterone
| [9] 1 1, 2, 3, 13, 60, 76, 78, 113, 265 |
26 |
AR
| [4] Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer | D00957
D00957
|
Testosterone
| [9] 1 1, 2, 3, 13, 60, 76, 78, 113, 265 |
27 |
AR
| [4] Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer | D00958
D00958
|
Testosterone
| [9] 1 1, 2, 3, 13, 60, 76, 78, 113, 265 |
28 |
AR
| [4] Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer | D00959
D00959
|
Testosterone
| [9] 1 1, 2, 3, 13, 60, 76, 78, 113, 265 |
29 |
AR
| [4] Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer | D06085
D06085
|
Testosterone
| [9] 1 1, 2, 3, 13, 60, 76, 78, 113, 265 |
30 |
AR
| [4] Oocyte meiosis Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer | D06087
D06087
|
Testosterone
| [9] 1 1, 2, 3, 13, 60, 76, 78, 113, 265 |
31 |
PGR
| [5] Oocyte meiosis Oocyte meiosis, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Chemical carcinogenesis - receptor activation, Breast cancer | D00066
D00066
|
Progesterone
| [1] 76 76 |
32 |
PGR
| [5] Oocyte meiosis Oocyte meiosis, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Chemical carcinogenesis - receptor activation, Breast cancer | D00952
D00952
|
Megestrol acetate
| [1] 76 76 |
33 |
PGR
| [5] Oocyte meiosis Oocyte meiosis, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Chemical carcinogenesis - receptor activation, Breast cancer | D08167
D08167
|
Megestrol acetate
| [1] 76 76 |